- Home
- PGC vs SGP Comparison
PGC vs SGP Comparison
Compare PGC & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PGC | SGP |
|---|---|---|
| Founded | 1921 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 836.7M | 968.0M |
| IPO Year | 1997 | 2026 |
Fundamental Metrics
Financial Performance| Metric | PGC | SGP |
|---|---|---|
| Price | $44.68 | $28.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $40.50 | ★ $45.00 |
| AVG Volume (30 Days) | 92.4K | ★ 95.9K |
| Earning Date | 04-22-2026 | 05-15-2026 |
| Dividend Yield | ★ 0.48% | N/A |
| EPS Growth | ★ 13.51 | N/A |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $282,995,000.00 | N/A |
| Revenue This Year | $32.39 | N/A |
| Revenue Next Year | $12.64 | N/A |
| P/E Ratio | $27.38 | ★ N/A |
| Revenue Growth | ★ 24.05 | N/A |
| 52 Week Low | $24.71 | $17.06 |
| 52 Week High | $49.14 | $30.56 |
Technical Indicators
Market Signals| Indicator | PGC | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 43.70 | 57.02 |
| Support Level | $44.85 | $25.00 |
| Resistance Level | $47.32 | $29.90 |
| Average True Range (ATR) | 0.94 | 1.59 |
| MACD | -0.05 | -0.16 |
| Stochastic Oscillator | 32.39 | 41.77 |
Price Performance
Historical ComparisonAbout PGC Peapack-Gladstone Financial Corporation
Peapack Gladstone Financial Corp is a bank holding company. Through its subsidiaries, the company offers various wealth management, investment banking, and commercial and personal banking solutions to its clients. The company has two reportable segments: Banking, which generates the maximum revenue, and Wealth Management. The Banking segment includes commercial, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; escrow management; deposit generation; operation of ATMs; telephone and internet banking services; credit card services, etc. The Wealth Management segment offers investment management services for individuals and institutions; personal trust services; and other financial planning and advisory services.
About SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.